Validation of cytogenetic-based risk stratification in primary myelofibrosis

Blood. 2010 Apr 1;115(13):2719-20. doi: 10.1182/blood-2009-12-258988.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Chromosome Aberrations*
  • Chromosome Deletion
  • Cytogenetic Analysis*
  • Female
  • Humans
  • Janus Kinase 2 / physiology
  • Kaplan-Meier Estimate
  • Karyotyping
  • Male
  • Middle Aged
  • Primary Myelofibrosis / epidemiology*
  • Primary Myelofibrosis / genetics
  • Primary Myelofibrosis / pathology
  • Prognosis
  • Risk Assessment
  • Young Adult

Substances

  • JAK2 protein, human
  • Janus Kinase 2